Evidence-Based Medicine
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 21, 2014; 20(31): 10900-10907
Published online Aug 21, 2014. doi: 10.3748/wjg.v20.i31.10900
Table 2 Long-term survival model for hepatocellular carcinoma patients after liver transplantation
VariablesRegression coefficientRegression coefficient SEP valueHazard ratio95%CI
Milan1
AFP (logevalue)0.0930.0310.0031.0971.032-1.167
Intraoperative blood loss0.0380.009< 0.0011.0391.021-1.057
Retransplantation1.4290.5220.0064.1731.501-11.604
Criteria exceeded1.5040.253< 0.0014.5002.741-7.386
University of California San Francisco2
AFP (logevalue)0.0900.0310.0031.0941.030-1.161
Intraoperative blood loss0.0380.009< 0.0011.0391.022-1.057
Retransplantation1.3730.5220.0093.9471.419-10.976
Criteria exceeded1.5550.242< 0.0014.7372.950-7.607
Shanghai Fudan3
AFP (logevalue)0.0910.0310.0031.0961.031-1.165
Intraoperative blood loss0.0340.008< 0.0011.0351.018-1.052
Retransplantation1.2960.5230.0133.6541.311-10.182
Criteria exceeded1.3610.213< 0.0013.8992.566-5.924
Hangzhou4
TB (logevalue)0.1860.0940.0491.2041.001-1.449
Intraoperative blood loss0.0200.0100.0461.0201.000-1.040
Retransplantation1.3120.5200.0123.7151.340-10.295
Criteria exceeded1.5200.190< 0.0014.5703.149-6.633